Be in the know. 15 key reads for Thursday…

  1. Alibaba’s Earnings Aren’t Bad but the Stock Plunges. Here’s What to Like. (barrons)
  2. Is the Senate gearing up to actually pass drug pricing legislation? (statnews)
  3. Whitmer signs bills with hopes of ‘significant’ impact on prescription drug prices (detroitnews)
  4. Wall Street’s ‘Fear Gauge’ Skyrockets (barrons)
  5. SPACs Are Scrambling to Find Mergers. What That Means for Investors. (barrons)
  6. Russia Launches Attack on Ukraine (barrons)
  7. Swallow your fear and prepare for a ‘relief rally,’ says analyst, as Russia invasion in Ukraine sparks stock-market maelstrom (marketwatch)
  8. Opinion: ‘We are in new, dangerous territory’: Here’s how NATO must respond to a Russian ‘triple threat’ that goes beyond Ukraine (marketwatch)
  9. SALT Alternative Takes Shape as Democrats Move Past Biden Plan (bloomberg)
  10. Jobless claims total 232,000, slightly less than expected; Q4 GDP revised up to 7% (cnbc)
  11. EIA data show an increase in weekly U.S. crude supplies amid rising oil prices (marketwatch)
  12. Fed’s Barkin Says ‘Time Will Tell’ If Ukraine Changes Rate Outlook (bloomberg)
  13. Russian troops pour into Ukraine on three fronts (ft)
  14. Gilead Sciences (GILD) Has an 80% Chance of Trading Higher on this Catalyst – Morgan Stanley (streetinsider)
  15. Warren Buffett has warned against hoarding cash, gold, or bitcoin during wars — and touted stocks as the safest long-term bet (businessinsider)